EMEA-000306-PIP01-08-M04
Key facts
| Invented name |
Elonva
|
| Active substance |
corifollitropin alfa
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0143/2019
|
| PIP number |
EMEA-000306-PIP01-08-M04
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of hypogonadotrophic hypogonadism
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Merck, Sharp & Dohme (Europe) Inc.
Tel. +31 412770000 |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000306-PIP01-08-M04
|
| Compliance opinion date |
29/01/2021
|
| Compliance outcome |
positive
|